Abstract
Background: While endovascular stroke treatment (EST) of large vessel occlusions in acute ischemic stroke (AIS) is proven to be safe and effective, there are subgroups of patients with increased rates of hemorrhages. Our goal was to identify risk factors for intracerebral hemorrhage and to assess whether acute carotid artery stenting (CAS) was associated with increased bleeding rates. Methods: We performed a retrospective analysis of our monocentric prospective stroke registry in the period from May 2010 to May 2018 and compared AIS patients receiving EST with (n = 73) versus without acute CAS (n = 548). Patients with intracranial stents, intra-arterial thrombolysis, or dissection of the carotid artery were excluded. Results: Parenchymal hemorrhage rates (PH2 according to the ECASS classification) and symptomatic hemorrhage (sICH) rates were increased in EST patients receiving CAS with odds being 6.3 (PH2) and 6.5 (sICH) times higher (PH2 17.8 vs. 3.3%, p < 0.001 and sICH: 16.4 vs. 2.9%, p < 0.001). Additional systemic thrombolysis with rtPA (IVRTPA) was no risk factor for cerebral hemorrhage (p = 0.213). Conclusion: AIS patients receiving EST with acute CAS and consecutive tirofiban or dual antiplatelet therapy suffered from an increased risk of relevant secondary intracranial bleeding. After adjusting for confounders, tirofiban and dual antiplatelet therapy were associated with higher bleeding rates.
References
1.
Goyal
M
, Menon
BK
, van Zwam
WH
, Dippel
DWJ
, Mitchel
PJ
, Demchuk
AM
, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
. Lancet
. 2016 Apr 23
;387
(10029
):1723
–31
.2.
Jansen
IGH
, Mulder
MJHL
, Goldhoorn
RB
. Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry); MR CLEAN registry investigators
. BMJ
. 2018 Mar 9
;360
:k949
.3.
Nogueira
RG
, Jadhav
AP
, Haussen
DC
, Bonafe
A
, Budzik
RF
, Bhuva
P
, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct
. N Engl J Med
. 2018
;378
:11
–21
.4.
Weisenburger-Lile
D
, Blanc
R
, Kyheng
M
, Desilles
JP
, Labreuche
J
, Piotin
M
, et al. Direct admission versus secondary transfer for acute stroke patients treated with intravenous thrombolysis and thrombectomy: insights from the endovascular treatment in ischemic stroke registry
. Cerebrovasc Dis
. 2019 May 7
;47
(3–4
):112
–20
. .5.
Heck
DV
, Brown
MD
. Carotid stenting and intracranial thrombectomy for treatment of acute stroke due to tandem occlusions with aggressive antiplatelet therapy may be associated with a high incidence of intracranial hemorrhage
. J Neurointerv Surg
. 2015 Mar
;7
(3
):170
–5
. .6.
Brott
T
, Adams
HP
, Olinger
CP
, Marler
JR
, Barsan
WG
, Biller
J
, et al. Measurements of acute cerebral infarction: a clinical examination scale
. Stroke
. 1989 Jul
;20
(7
):864
–70
. .7.
Pexman
JH
, Barber
PA
, Hill
MD
, Sevick
RJ
, Demchuk
AM
, Hudon
ME
, et al. Use of the alberta stroke program early CT score (ASPECTS) for assessing CT scans in patients with acute stroke
. AJNR Am J Neuroradiol
. 2001 Sep
;22
(8
):1534
–42
..8.
Fugate
JE
, Klunder
AM
, Kallmes
DF
. What is meant by “TICI”?
AJNR Am J Neuroradiol
. 2013
;34
(9
):1792
–7
. .9.
Trouillas
P
, von Kummer
R
. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke
. Stroke
. 2006 Feb 1
;37
(2
):556
. .10.
Van Swieten
JC
, Koudstaal
PJ
, Visser
MC
, Schouten
HJ
, van Gijn
J
. Interobserver agreement for the assessment of handicap in stroke patients
. Stroke
. 1988 May
;19
(5
):604
.11.
Menon
BK
, Saver
JL
, Prabhakaran
S
, Reeves
M
, Liang
L
, Oslan
DM
, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator
. Stroke
. 2012 Sep
;43
(9
):2293
–9
. .12.
Kaesmacher
J
, Kaesmacher
M
, Maegerlein
C
, Zimmer
C
, Gersing
AS
, Wunderlich
S
, et al. Hemorrhagic transformations after thrombectomy: risk factors and clinical relevance
. Cerebrovasc Dis
. 2017
;43
(5–6
):294
–304
. .13.
Anadani
M
, Spiotta
AM
, Alawieh
A
, Turjman
F
, Piotin
M
, Haussen
DC
, et al. Emergent carotid stenting plus thrombectomy after thrombolysis in tandem strokes: analysis of the TITAN registry
. Stroke
. 2019
;50
(8
):2250
–2
. .M14.
Cohen
JE
, Gomori
JM
, Rajz
G
, Itshayek
E
, Eichel
R
, Leker
RR
. Extracranial carotid artery stenting followed by intracranial stent-based thrombectomy for acute tandem occlusive disease
. J Neurointerv Surg
. 2015 Jun
;7
(6
):412
–7
. .15.
Steglich-Arnholm
H
, Holtmannspötter
M
, Kondziella
D
, Wagner
A
, Stavngaard
T
, Cronqvist
ME
, et al. Thrombectomy assisted by carotid stenting in acute ischemic stroke management: benefits and harms
. J Neurol
. 2015 Dec
;262
(12
):2668
–75
. .16.
Behme
D
, Mpotsaris
A
, Zeyen
P
, Psychogios
MN
, Kowoll
A
, Maurer
CJ
, et al. Emergency stenting of the extracranial internal carotid artery in combination with anterior circulation thrombectomy in acute ischemic stroke: a retrospective multicenter study
. AJNR Am J Neuroradiol
. 2015 Aug
;36
(12
):2340
–5
. .17.
Papanagiotou
P
, Haussen
DC
, Turjman
F
, Labreuche
J
, Piotin
M
, Kastrup
A
, et al. Carotid stenting with antithrombotic agents and intracranial thrombectomy leads to the highest recanalization rate in patients with acute stroke with tandem lesions
. JACC Cardiovasc Interv
. 2018 Jul 9
;11
(13
):1290
–9
. .18.
Wang
Y
, Pan
Y
, Zhao
X
, Li
H
, Wang
D
, Johnston
SC
, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes
. Circulation
. 2015 May 8
;132
(1
):40
. .19.
Leung
LY
, Albright
KC
, Boehme
AK
, Tarsia
J
, Shah
KR
, Siegler
JE
, et al. Short-term bleeding events observed with clopidogrel loading in acute ischemic stroke patients
. J Stroke Cerebrovasc Dis
. 2013 Oct
;22
(7
):1184
–9
. .20.
Tillman
H
, Johnston
S
, Farrant
M
, Barsan
W
, Elm
JJ
, Kim
AS
, et al. Risk for major hemorrhages in patients receiving clopidogrel and aspirin compared with aspirin alone after transient ischemic attack or minor ischemic stroke: a secondary analysis of the POINT randomized clinical trial
. JAMA Neurol
. 2019 Jul 1
;76
(7
):774
–82
.21.
Neuberger
U
, Seker
F
, Schönenberger
S
, Nagel
S
, Ringleb
PA
, Bendszus
M
, et al. Prediction of intracranial hemorrhages after mechanical thrombectomy of basilar artery occlusion
. J Neurointerv Surg
. 2019 Dec
;11
(12
):1181
–6
. .22.
Zinkstok
SM
, Roos
YB
. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial, ARTIS investigators
. Lancet
. 2012 Aug 25
;380
(9843
):731
–7
.23.
Kellert
L
, Hametner
C
, Rohde
S
, Bendszus
M
, Hacke
W
, Ringleb
P
, et al. Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome
. Stroke
. 2013 May
;44
(5
):1453
–5
. .24.
Singh
R
, Dekeyzer
S
, Reich
A
, Kotelis
D
, Gombert
A
, Wiesmann
M
, et al. Emergent carotid endarterectomy instead of carotid artery stenting reduces delayed hemorrhage in thrombectomy stroke patients
. Clin Neuroradiol
. 2020 Sep 17
. Online ahead of print
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
